Results for tag: "Carpal Tunnel Syndrome Drug"

The Carpal Tunnel Syndrome Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat the symptoms of carpal tunnel syndrome, a condition caused by compression of the median nerve in the wrist. Common treatments include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and other medications. Surgery is also an option for more severe cases. The Carpal Tunnel Syndrome Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Other companies include AbbVie, Sanofi, and Allergan. Show Less Read more